Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
2.240
-0.050 (-2.18%)
At close: Sep 4, 2026, 4:00 PM EDT
2.247
+0.007 (0.32%)
After-hours: Sep 4, 2026, 7:39 PM EDT
Autolus Therapeutics Market Cap
Autolus Therapeutics has a market cap or net worth of $596.2 million as of September 4, 2026. Its market cap has increased by 55.59% in one year.
Market Cap
596.20M
Enterprise Value
762.39M
1-Year Change
55.59%
Ranking
Category
Stock Price
$2.24
ChartMarket Cap Chart
Since June 22, 2018, Autolus Therapeutics's market cap has decreased from $944.40M to $596.20M, a decrease of -36.87%. That is a compound annual growth rate of -5.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 596.20M | 12.58% |
| Dec 31, 2025 | 529.60M | -15.32% |
| Dec 31, 2024 | 625.40M | -44.19% |
| Dec 29, 2023 | 1.12B | 546.94% |
| Dec 30, 2022 | 173.20M | -54.23% |
| Dec 31, 2021 | 378.40M | -19.08% |
| Dec 31, 2020 | 467.60M | -21.25% |
| Dec 31, 2019 | 593.80M | -54.96% |
| Dec 31, 2018 | 1.32B | 39.60% |
| Jun 22, 2018 | 944.40M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MiMedx Group | 645.72M |
| Altimmune | 628.29M |
| BlossomHill Therapeutics | 613.49M |
| Arvinas | 608.75M |
| REGENXBIO | 607.32M |
| Eikon Therapeutics | 593.65M |
| Cabaletta Bio | 590.02M |
| Tectonic Therapeutic | 584.92M |